vs
CATO CORP（CATO）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是CATO CORP的1.4倍（$219.9M vs $155.4M），Orthofix Medical Inc.净利率更高（-1.0% vs -3.3%，领先2.3%），CATO CORP同比增速更快（6.3% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-12.9M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -5.7%）
凯拓集团（Cato Corporation）是美国女性时装及配饰零售商，总部位于北卡罗来纳州夏洛特市。截至2016年1月，该公司旗下共运营1372家门店，覆盖Cato、Cato Plus、It's Fashion、It's Fashion Metro与Versona多个品牌。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
CATO vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.4倍
$155.4M
营收增速更快
CATO
高出4.3%
2.0%
净利率更高
OFIX
高出2.3%
-3.3%
自由现金流更多
OFIX
多$29.7M
$-12.9M
两年增速更快
OFIX
近两年复合增速
-5.7%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $155.4M | $219.9M |
| 净利润 | $-5.2M | $-2.2M |
| 毛利率 | 32.7% | 71.1% |
| 营业利润率 | -5.3% | 0.2% |
| 净利率 | -3.3% | -1.0% |
| 营收同比 | 6.3% | 2.0% |
| 净利润同比 | 65.6% | 92.4% |
| 每股收益（稀释后） | $-0.28 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CATOOFIX
| Q4 25 | $155.4M | $219.9M | ||
| Q3 25 | $176.5M | $205.6M | ||
| Q2 25 | $170.2M | $203.1M | ||
| Q1 25 | $157.9M | $193.6M | ||
| Q4 24 | $146.2M | $215.7M | ||
| Q3 24 | $168.6M | $196.6M | ||
| Q2 24 | $177.1M | $198.6M | ||
| Q1 24 | $174.9M | $188.6M |
净利润CATOOFIX
| Q4 25 | $-5.2M | $-2.2M | ||
| Q3 25 | $6.8M | $-22.8M | ||
| Q2 25 | $3.3M | $-14.1M | ||
| Q1 25 | $-14.1M | $-53.1M | ||
| Q4 24 | $-15.1M | $-29.1M | ||
| Q3 24 | $95.0K | $-27.4M | ||
| Q2 24 | $11.0M | $-33.4M | ||
| Q1 24 | — | $-36.0M |
毛利率CATOOFIX
| Q4 25 | 32.7% | 71.1% | ||
| Q3 25 | 36.8% | 72.2% | ||
| Q2 25 | 35.8% | 68.7% | ||
| Q1 25 | 29.2% | 62.8% | ||
| Q4 24 | 29.6% | 69.0% | ||
| Q3 24 | 35.3% | 68.7% | ||
| Q2 24 | 36.5% | 67.8% | ||
| Q1 24 | 32.1% | 67.5% |
营业利润率CATOOFIX
| Q4 25 | -5.3% | 0.2% | ||
| Q3 25 | 3.1% | -8.3% | ||
| Q2 25 | 2.0% | -7.9% | ||
| Q1 25 | -15.2% | -25.2% | ||
| Q4 24 | -11.6% | -5.3% | ||
| Q3 24 | -0.4% | -9.6% | ||
| Q2 24 | 3.5% | -12.5% | ||
| Q1 24 | -9.5% | -15.6% |
净利率CATOOFIX
| Q4 25 | -3.3% | -1.0% | ||
| Q3 25 | 3.9% | -11.1% | ||
| Q2 25 | 1.9% | -6.9% | ||
| Q1 25 | -8.9% | -27.4% | ||
| Q4 24 | -10.3% | -13.5% | ||
| Q3 24 | 0.1% | -13.9% | ||
| Q2 24 | 6.2% | -16.8% | ||
| Q1 24 | — | -19.1% |
每股收益（稀释后）CATOOFIX
| Q4 25 | $-0.28 | $-0.05 | ||
| Q3 25 | $0.35 | $-0.57 | ||
| Q2 25 | $0.17 | $-0.36 | ||
| Q1 25 | $-0.73 | $-1.35 | ||
| Q4 24 | $-0.79 | $-0.76 | ||
| Q3 24 | $0.01 | $-0.71 | ||
| Q2 24 | $0.54 | $-0.88 | ||
| Q1 24 | $-1.15 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $79.0M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $167.6M | $450.0M |
| 总资产 | $450.2M | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CATOOFIX
| Q4 25 | $79.0M | $82.0M | ||
| Q3 25 | $90.8M | $62.9M | ||
| Q2 25 | $80.0M | $65.6M | ||
| Q1 25 | $77.7M | $58.0M | ||
| Q4 24 | $86.2M | $83.2M | ||
| Q3 24 | $104.7M | $30.1M | ||
| Q2 24 | $105.4M | $26.4M | ||
| Q1 24 | $103.0M | $27.0M |
总债务CATOOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益CATOOFIX
| Q4 25 | $167.6M | $450.0M | ||
| Q3 25 | $172.2M | $442.5M | ||
| Q2 25 | $164.9M | $458.3M | ||
| Q1 25 | $162.3M | $458.3M | ||
| Q4 24 | $177.1M | $503.1M | ||
| Q3 24 | $195.1M | $525.9M | ||
| Q2 24 | $196.9M | $546.0M | ||
| Q1 24 | $192.3M | $570.3M |
总资产CATOOFIX
| Q4 25 | $450.2M | $850.6M | ||
| Q3 25 | $436.9M | $832.6M | ||
| Q2 25 | $440.8M | $837.2M | ||
| Q1 25 | $452.4M | $823.1M | ||
| Q4 24 | $424.4M | $893.3M | ||
| Q3 24 | $455.6M | $867.9M | ||
| Q2 24 | $477.1M | $882.0M | ||
| Q1 24 | $486.8M | $906.0M |
负债/权益比CATOOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-12.4M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-12.9M | $16.8M |
| 自由现金流率自由现金流/营收 | -8.3% | 7.6% |
| 资本支出强度资本支出/营收 | 0.3% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-7.5M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流CATOOFIX
| Q4 25 | $-12.4M | $27.7M | ||
| Q3 25 | $11.8M | $12.4M | ||
| Q2 25 | $3.9M | $11.6M | ||
| Q1 25 | $-6.5M | $-18.4M | ||
| Q4 24 | $-22.1M | $23.7M | ||
| Q3 24 | $3.1M | $11.7M | ||
| Q2 24 | $5.7M | $9.0M | ||
| Q1 24 | $-11.2M | $-18.6M |
自由现金流CATOOFIX
| Q4 25 | $-12.9M | $16.8M | ||
| Q3 25 | $10.4M | $2.5M | ||
| Q2 25 | $2.8M | $4.5M | ||
| Q1 25 | $-7.8M | $-25.1M | ||
| Q4 24 | $-23.8M | $15.2M | ||
| Q3 24 | $1.6M | $6.3M | ||
| Q2 24 | $2.4M | $-360.0K | ||
| Q1 24 | $-13.5M | $-29.1M |
自由现金流率CATOOFIX
| Q4 25 | -8.3% | 7.6% | ||
| Q3 25 | 5.9% | 1.2% | ||
| Q2 25 | 1.7% | 2.2% | ||
| Q1 25 | -5.0% | -13.0% | ||
| Q4 24 | -16.3% | 7.0% | ||
| Q3 24 | 0.9% | 3.2% | ||
| Q2 24 | 1.4% | -0.2% | ||
| Q1 24 | -7.7% | -15.4% |
资本支出强度CATOOFIX
| Q4 25 | 0.3% | 4.9% | ||
| Q3 25 | 0.8% | 4.8% | ||
| Q2 25 | 0.6% | 3.5% | ||
| Q1 25 | 0.9% | 3.5% | ||
| Q4 24 | 1.2% | 4.0% | ||
| Q3 24 | 0.9% | 2.7% | ||
| Q2 24 | 1.8% | 4.7% | ||
| Q1 24 | 1.3% | 5.6% |
现金转化率CATOOFIX
| Q4 25 | — | — | ||
| Q3 25 | 1.72× | — | ||
| Q2 25 | 1.17× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 32.95× | — | ||
| Q2 24 | 0.52× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CATO
| Retail Segment | $154.7M | 100% |
| Credit Card | $5.3M | 3% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
